A Conversation With Dr. E. Mitchell
Seymour of the University of Michigan Institute for Clinical and
Health Research
Dr. E. Mitchell Seymour did not follow a conventional path on his
way to becoming a highly respected nutrition researcher, as his
undergraduate degree was not in the field. Instead, it was his
election as student Food, Alcohol, and Health Commissioner at the
University of Notre Dame that sparked his interest. In that
position, he worked with the university's food service and its head
dietician to select healthy choices for campus menus. After taking
a few nutrition courses to help him in his role as commissioner, he
knew he had found his calling.
After returning to Michigan, Dr. Seymour took a capstone research
course on nutrition science at Michigan State, and subsequently
enrolled in graduate school there. It was his graduate faculty that
introduced him to ASN. Many were active members who attended ASN's
Scientific Sessions and Annual Meeting at Experimental Biology
regularly. On their recommendation, Dr. Seymour did the
same--joining the organization and attending his first EB meeting
in 1997.
Now, Dr. Seymour's path has led him to his current position at the
University of Michigan's Cardioprotection Research Laboratory,
where he works as a lab manager for Dr. Steven F. Bolling. Dr.
Seymour was recently kind enough to take time to tell us a bit
about their latest findings and to discuss the ways in which ASN
has influenced his unique journey as a nutrition researcher.
Interviewer: What is it that
you find most helpful about ASN membership?
Dr. Seymour: For me, it is
the access to information, and the access to the Research Interest
Sections (RIS) in particular. Within those groups you get to know
who the thought leaders are in your area of interest, which leads
you to pay more attention to the publications and the projects they
are working on. That provides guidance for your own career
path, which is very important.
Interviewer: As a
researcher, what aspects of ASN's Scientific Sessions and Annual
Meeting at Experimental Biology (EB) meeting do you find most
exciting?
Dr. Seymour: The special
interest poster sessions, because they allow you to interact with
those thought leaders I mentioned. They come to the poster
sessions, and ask very thoughtful, sometimes very probing questions
that have the potential to significantly alter your
experiments. The ASN business meetings are also very useful
because they give you an idea of what is going on at the leadership
level within ASN.
Interviewer: And what are
you looking forward to most about this year's meeting?
Dr. Seymour: The Dietary
Bioactives sessions are always my favorite, since that is my area
of interest. I'm also interested to hear some of the discussions
regarding whole foods versus nutritional supplements for affecting
health and disease as well as the effects of fruit- and
vegetable-rich diets.
Interviewer: Could you tell
us about your own research with the cardio protection research
laboratory?
Dr. Seymour: Our lab is
split into two sections. On one hand, we have basic science and
cardiac pathology investigations that we conduct in animal models.
On the other, we have the clinical studies that work with patients
with hypertension and heart failure or those who may be at risk for
heart failure.
In the lab, we study animals who have hypertension and who are
either obese or lean and some of them may be prone to heart failure
or stroke. We use whole food models, and currently we are
looking at the effects of different fruits--such as apples, grapes,
cherries, and blueberries--to study their effect on the trajectory
of cardiac dysfunction that occurs after long-term
hypertension. We are very interested in the specific changes
in the heart as well as genetic changes that are associated with
the diet. There is a lot of controversy right now around
bioavailability--can these phytochemicals in fruits and vegetables
have an effect if we do not find measurable amounts in the tissue,
or if those levels are very low? We think that the answer to that
question is, “Yes, you can have an effect with low levels of these
compounds.”
In the clinical studies we have two different investigations. One,
a double-blind crossover study that just started, is looking at the
effects of grapeseed extract versus placebo in heart failure
patients, measuring different cardiac parameters over the course of
six weeks. We are also conducting baseline and follow up
dietary assessments in these subjects to ensure that they are not
altering their diet as part of the trial.
The other study, which is on its way to completion, is the DASH
Heart Failure Study, which includes a three-week intervention with
a DASH-style diet. We are providing the diet for these subjects and
studying differences between baseline blood pressure and endpoint
blood pressure, kidney function, cardiac function, vascular
function, antioxidant capacity, and the changes in phytochemical
intake. It is amazing that this short intervention has shown
a significant reduction in blood pressure and an improvement in
other markers. This was meant to be a pilot study to
determine if we can lower blood pressure with this type of
diet. What we are now going to do is follow up to determine
if patients can sustain this diet and determine ways that we can
help them achieve that goal.
Interviewer: Is there
anything else that you would like ASN members to know?
I really encourage them to check out ASN's Scientific Sessions and
Annual Meeting at Experimental Biology. I have been going every
year since 1997, and the opportunities that it provides for
information and networking are truly unparalleled. I also encourage
them to be active in the organization's special interest groups
because of the networking and mentoring opportunities that doing so
has offered for me, personally; I hope that it will provide them
with the same benefits.
February 2011